Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.

Subscribe to the Merantix Momentum Newsletter now.

The latest industry news, interviews, technologies and resources.

The Great Rewiring: A Look Back

What became apparent in Davos was that AI moved from aspiration to implementation and began to reorganize decisions, systems, and leadership in various industries.

AI is now part of our culture. Communities will determine what comes next

How AI is transforming our society, and why it is not technology alone, but communities, values, and responsibility that will determine the future we shape with AI.

Article

Can a diverse team develop better AI? The answer is a resounding yes.

Innovation in AI starts with the people who shape it. At Merantix Momentum, we believe that diverse teams develop fairer, more effective AI - and turn inclusion into a competitive advantage.

Article

"AI in Market Access: Do We Have What It Takes?"

Interview with Menasheh Fogel - On AI in Market Access, Organizational Challenges, and the Future of Data-Driven Pricing and Reimbursement Strategies.

Article

AI Readiness in the Industrial Sector - Do's and Don'ts

To our first edition of "The AI Interview" series on AI Readiness in the Industrial Sector.

Data-driven to the drug of tomorrow

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.